[1] |
MÚÑEZ RUBIO E, RAMOS MARTÍNEZ A, FERNÁNDEZ CRUZ A. Fosfomycin in antimicrobial stewardship programs[J]. Rev Esp Quimioter, 2019, 32(Suppl 1):62-66.
|
[2] |
LEE Y C, CHEN P Y, WANG J T, et al. Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus[J]. Antimicrob Resist Infect Control, 2020, 9(1):135.
DOI
URL
|
[3] |
FALAGAS M E, ATHANASAKI F, VOULGARIS G L, et a1. Resistance to fosfomycin:mechanisms,frequency and clinical consequences[J]. Int J Antimicrob Agents, 2019, 53(1):22-28.
DOI
URL
|
[4] |
ZHANG X, BI W, CHEN L, et al. Molecular mechanisms and epidemiology of fosfomycin resistance in Enterococci isolated from patients at a teaching hospital in China,2013-2016[J]. J Glob Antimicrob Resist, 2020, 20:191-196.
DOI
URL
|
[5] |
SEOK H, CHOI J Y, WI Y M, et al. Fosfomycin resistance in Escherichia coli isolates from South Korea and in vitro activity of fosfomycin alone and in combination with other antibiotics[J]. Antibiotics(Basel), 2020, 9(3):112.
|
[6] |
LIU P, CHEN S, WU Z Y, et al. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae[J]. J Glob Antimicrob Resist, 2020, 22:238-243.
DOI
URL
|
[7] |
DÍEZ-AGUILAR M, CANTÓN R. New microbiological aspects of fosfomycin[J]. Rev Esp Quimioter, 2019, 32(Suppl 1):8-18.
|
[8] |
XU W, CHEN T, WANG H, et al. Molecular mechanisms and epidemiology of fosfomycin resistance in Staphylococcus aureus isolated from patients at a teaching hospital in China[J]. Front Microbiol, 2020, 11:1290.
DOI
URL
|
[9] |
SORLOZANO-PUERTO A, LOPEZ-MACHADO I, ALBERTUZ-CRESPO M, et al. Characterization of fosfomycin and nitrofurantoin resistance mechanisms in Escherichia coli isolated in clinical urine samples[J]. Antibiotics(Basel), 2020, 9(9):534.
|
[10] |
SINGKHAM-IN U, MUHUMMUDAREE N, CHATSUWAN T. FosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates[J]. PLoS One, 2020, 15(8):e0237474.
|
[11] |
CATTOIR V, POURBAIX A, MAGNAN M, et al. Novel chromosomal mutations responsible for fosfomycin resistance in Escherichia coli[J]. Front Microbiol, 2020, 11:575031.
DOI
URL
|
[12] |
HUANG Y, LIN Q, ZHOU Q, et al. Identification of fosA10,a novel plasmid-mediated fosfomycin resistance gene of Klebsiella pneumonia origin,in Escherichia coli[J]. Infect Drug Resist, 2020, 13:1273-1279.
DOI
URL
|
[13] |
ZURFLUH K, TREIER A, SCHMITT K, et al. Mobile fosfomycin resistance genes in Enterobacteriaceae-an increasing threat[J]. Microbiologyopen, 2020, 9(12):e1135.
|
[14] |
YANG T Y, LU P L, TSENG S P. Update on fosfomycin-modified genes in Enterobacteriaceae[J]. J Microbiol Immunol Infect, 2019, 52(1):9-21.
DOI
URL
|
[15] |
WANG H, MIN C, LI J, et al. Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China[J]. BMC Microbiol, 2021, 21(1):109.
DOI
URL
|
[16] |
HUANG L, CAO M, HU Y, et al. Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China[J]. Int J Antimicrob Agents, 2021, 57(1):106226.
DOI
URL
|
[17] |
MOWLABOCCUS S, DALEY D, PANG S, et al. Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia[J]. Int J Antimicrob Agents, 2020, 56(4):106121.
DOI
URL
|
[18] |
LORAS C, GONZÁLEZ-PRIETO A, PÉREZ-VÁZQUEZ M, et al. Prevalence, detection and characterisation of fosfomycin-resistant Escherichia coli strains carrying fosA genes in community of Madrid,Spain[J]. J Glob Antimicrob Resist, 2021, 25:137-141.
DOI
URL
|
[19] |
POIREL L, VUILLEMIN X, KIEFFER N, et al. Identification of fosA8,a plasmid-encoded fosfomycin resistance determinant from Escherichia coli,and its origin in Leclercia adecarboxylata[J]. Antimicrob Agents Chemother, 2019, 63(11):e01403-e01419.
|
[20] |
TEN DOESSCHATE T, ABBOTT I J, WILLEMS R J L, et al. In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora[J]. J Antimicrob Chemother, 2019, 74(12):3630-3632.
DOI
URL
|
[21] |
ITO R, MUSTAPHA M M, TOMICH A D, et al. Widespread fosfomycin resistance in Gram-negative bacteria attributable to the chromosomal fosA gene[J]. mBio, 2017, 8(4):e00749-17.
|
[22] |
KIEFFER N, POIREL L, MUELLER L, et al. IS Ecp1-mediated transposition leads to fosfomycin and broad-spectrum cephalosporin resistance in Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2020, 64(5):e00150-20.
|
[23] |
CHEN C, XU X, QU T, et al. Prevalence of the fosfomycin-resistance determinant,fosB3,in Enterococcus faecium clinical isolates from China[J]. J Med Microbiol, 2014, 63(Pt 11):1484-1489.
DOI
URL
|
[24] |
MOTA M I, VÁZQUEZ S, CORNEJO C, et al. Does shiga toxin-producing Escherichia coli and Listeria monocytogenes contribute significantly to the burden of antimicrobial resistance in Uruguay?[J]. Front Vet Sci, 2020, 7:583930.
DOI
URL
|
[25] |
LEITE G C, PERDIGÃO-NETO L V, RUEDAS MARTINS R C, et al. Genetic factors involved in fosfomycin resistance of multidrug-resistant Acinetobacter baumannii[J]. Infect Genet Evol, 2021, 93:104943.
DOI
URL
|
[26] |
TRAVIS S, SHAY M R, MANABE S, et al. Characterization of the genomically encoded fosfomycin resistance enzyme from Mycobacterium abscessus[J]. Medchemcomm, 2019, 10(11):1948-1957.
DOI
URL
|
[27] |
KHABTHANI S, HAMEL M, BARON S A, et al. FosM,a new family of fosfomycin resistance genes identified in bacterial species isolated from human microbiota[J]. Antimicrob Agents Chemother, 2021, 65(2):e01712-e01720.
|
[28] |
KIEFFER N, POIREL L, DESCOMBES M C, et al. Characterization of fosL1,a plasmid-encoded fosfomycin resistance protein identified in Escherichia coli[J]. Antimicrob Agents Chemother, 2020, 64(4):e02042-19.
|
[29] |
KOBAYASHI S, KUZUYAMA T, SETO H. Characterization of the fomA and fomB gene products from Streptomyces wedmorensis,which confer fosfomycin resistance on Escherichia coli[J]. Antimicrob Agents Chemother, 2000, 44(3):647-650.
DOI
URL
|
[30] |
CASTAÑEDA-GARCÍA A, BLÁZQUEZ J, RODRÍGUEZ-ROJAS A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance[J]. Antibiotics(Basel), 2013, 2(2):217-236.
|
[31] |
ANDERSSON D I, NICOLOFF H, HJORT K. Mechanisms and clinical relevance of bacterial heteroresistance[J]. Nat Rev Microbiol, 2019, 17(8):479-496.
DOI
PMID
|
[32] |
ENGEL H, GUTIÉRREZ-FERNÁNDEZ J, FLÜCKIGER C, et al. Heteroresistance to fosfomycin is predominant in Streptococcus pneumoniae and depends on the murA1 gene[J]. Antimicrob Agents Chemother, 2013, 57(6):2801-2808.
DOI
URL
|
[33] |
PORTILLO-CALDERÓN I, ORTIZ-PADILLA M, RODRÍGUEZ-MARTÍNEZ J M, et al. Contribution of hypermutation to fosfomycin heteroresistance in Escherichia coli[J]. J Antimicrob Chemother, 2020, 75(8):2066-2075.
|